Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Neuropeptide Y (NPY) is a neuromodulator and co-transmitter widely expressed throughout the autonomic nervous system. It is predominantly located in sympathetic neurons supplying the vasculature and heart. It is also located in parasympathetic neurons and enteric neurons and released from platelets. NPY has a diverse range of physiological functions and plays a key role in the regulation of intestinal absorption, and neuromodulation of classical neurotransmitters. It is implicated in the pathogenesis of cardiovascular disease, in particular vasoconstriction, arrhythmia, angiogenesis, and cardiac remodeling. Elevated plasma levels of NPY are found in hypertension, myocardial infarction, and heart failure. There is growing support for the idea that the neuropeptide itself may play a detrimental role via Y1 receptor signaling, but that NPY fragments targeting other receptors may be beneficial. This chapter will focus on the structure and normal physiological function of NPY, followed by a discussion of its growing role in disease pathogenesis.

Original publication

DOI

10.1016/B978-0-323-85492-4.00124-1

Type

Chapter

Book title

Primer on the Autonomic Nervous System, Fourth Edition

Publication Date

01/01/2022

Pages

81 - 87